Genome Editing Market Size to Grow by USD 4.8 bn through 2020-2024
The genome editing market is expected to grow by USD 4.8 bn, accelerating at a CAGR of almost 17% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. View Free Sample Report
Genome Editing Market: Segmentation by End-user
This report provides a detailed analysis of the market by End-user (Pharmaceutical and biotechnology companies, Academic institute and research laboratories, and CROs) and Geography (North America, Europe, Asia, and ROW). This research report will provide insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges which are likely to influence market growth during the forecast period. These insights are expected to equip clients with reliable information based upon which they can design a growth strategy for their business and area of operations.
Genome Editing Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Eurofins Scientific SE, GenScript Biotech Corp., Horizon Discovery Group Plc, Integrated DNA Technologies Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Precision BioSciences Inc., Sangamo Therapeutics Inc., and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
Technavio has been monitoring the global Genome Editing Market and it is expected to grow by USD 4.8 billion progressing at a CAGR of almost 17% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. Download latest version with COVID-19 analysis Free Sample Report
North America to Lead the Way for Genomic Research
38% of the market’s growth will originate from North America during the forecast period with the US and Canada being the key markets for genome editing market. An increase in funding for genomic research and developments in precision medicine and personalized therapies will significantly drive genome editing market growth in this region over the forecast period.This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the genome editing market market size.
The increasing applications of genome engineering in therapeutics is driving market growth. The growing prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS is growing rapidly has led researchers to work on new gene-based therapies for treatment of these diseases. It has been observed that genome editing can prove to be an effective therapeutic tool for treating such ailments. For instance, genome editing can target host-dependent factors like co-receptor CCR5, thus preventing the entry of the HIV virus. Thus, the rise in the prevalence of these diseases will subsequently create demand for novel therapies using genome editing tools, and drive the genome editing market growth.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
Genome Editing Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Eurofins Scientific SE, GenScript Biotech Corp., Horizon Discovery Group Plc, Integrated DNA Technologies Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Precision BioSciences Inc., Sangamo Therapeutics Inc., and Thermo Fisher Scientific Inc.are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19 Download a Free Sample Report
Genome Editing Market: Key Highlights of the Report for 2020-2024
